Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Maijing Gene

Request full access

Maijing Gene is a gene detection technology company that specializes in R&D, production, and sales of molecular diagnostic products

Guangzhou, ChinaFounded 2015Biotech & Life Sciences

About Maijing Gene

Maijing Gene, established in 2015, is a medical technology company specializing in molecular diagnostic products. The company's headquarters are in Guangzhou International Bio Island, with additional branches in East, Central, and North China, and a research and development center in Silicon Valley, USA. The legal representative, Chairman, and CEO is Yang Dongcheng.

The firm focuses on the application of second-generation high-throughput sequencing technology in the field of precision medicine. Its business model encompasses both the sale of in-vitro diagnostic (IVD) products and the provision of medical testing services. The company serves a client base that includes patients, doctors, and medical institutions, aiming to provide comprehensive and convenient services. Maijing Gene's operations are supported by technical platforms such as qPCR, Sanger sequencing, and Next-Generation Sequencing (NGS). The company has established a third-party medical laboratory in Guangzhou to facilitate its testing services.

Maijing Gene has developed a range of diagnostic products for various cancers, including lung cancer, colorectal cancer, and other solid tumors. A significant milestone was achieved in October 2022, when its multi-gene companion diagnostic kit for lung cancer (MaiFeiJie®) received approval from the National Medical Products Administration (NMPA). This was followed by the approval of a rapid detection kit for colorectal cancer diagnostics (MaiChangJie®) in January 2024 and an NGS companion diagnostic kit (JingJianXin™) in August 2024. These approvals position Maijing Gene as a company with both NGS and PCR-based multi-gene companion diagnostic products for tumors in China.

Source: Dealroom company data

At a glance

Status
Operational
Employees
10
Open positions
None listed
Dealroom signal
36.3/100
Industry
Health, Marketing
Sub-industry
BioTechnology
Sector
Biotechnology, Genetics and genomics, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Dec 2022 $29M $115M Gongqingcheng Angu Fuge Investment · Hongtu Runda · Efung Capital · Mercedes-Benz Capital ↗
SERIES B✓Equity / VC Jan 2020 $14M $57M CASH Capital · Shenzhen Capital Group · Guoke Jiahe (Beijing) Investment Management —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Maijing Gene website traffic

Latest recorded traffic for Maijing Gene is 60 monthly website visits, down 79.3% over the last three months. Maijing Gene's team declined 9.1% over the past year.

Latest monthly visits60 3-month web change-79.3% 1-year team growth-9.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Maijing Gene in the Guangzhou ecosystem

Live from Dealroom

The Maijing Gene office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later5 investors entered at this stage

  • Gongqingcheng Angu Fuge Investment
  • Hongtu Runda
  • Efung Capital
  • Mercedes-Benz Capital
  • Jiuyou Capital
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Maijing Gene on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Maijing Gene’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.